Investing in and supporting the strategic growth of innovative therapeutic and enabling technology companies with the potential to transform patient care.
Portfolio 1
| Date | Name | Website | Total Raised | Location |
| 08.11.2022 | Zenas BioP... | zenasbio.c... | $118M | United Sta... |
Mentions in press and media 1
| Date | Title | Description | Source |
| 03.07.2023 | Startup led by former Seagen CEO Clay Siegall merges with pu... | Clay Siegall. (Seagen Photo) Morphimmune, a biotech company led by former Seagen CEO Clay Siegall, ... | geekwire.c... |